Millennium Management’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-537
| Closed | -$38K | – | 5596 |
|
|
2022
Q1 | $38K | Buy |
+537
| New | +$38K | ﹤0.01% | 4988 |
|
|
2018
Q3 | – | Sell |
-23
| Closed | -$48K | – | 3777 |
|
|
2018
Q2 | $48K | Sell |
23
-31
| -57% | -$64.7K | ﹤0.01% | 3332 |
|
|
2018
Q1 | $151K | Sell |
54
-38
| -41% | -$106K | ﹤0.01% | 3190 |
|
|
2017
Q4 | $410K | Sell |
92
-32
| -26% | -$143K | ﹤0.01% | 2963 |
|
|
2017
Q3 | $1.01M | Sell |
124
-23
| -16% | -$188K | ﹤0.01% | 2286 |
|
|
2017
Q2 | $729K | Buy |
147
+105
| +250% | +$521K | ﹤0.01% | 2392 |
|
|
2017
Q1 | $231K | Sell |
42
-44
| -51% | -$242K | ﹤0.01% | 2920 |
|
|
2016
Q4 | $576K | Buy |
+86
| New | +$576K | ﹤0.01% | 2412 |
|
|
2016
Q3 | – | Sell |
-6
| Closed | -$92K | – | 3287 |
|
|
2016
Q2 | $92K | Sell |
6
-8
| -57% | -$123K | ﹤0.01% | 2796 |
|
|
2016
Q1 | $285K | Buy |
14
+7
| +100% | +$143K | ﹤0.01% | 2554 |
|
|
2015
Q4 | $145K | Buy |
7
+4
| +133% | +$82.9K | ﹤0.01% | 2974 |
|
|
2015
Q3 | $65K | Sell |
3
-1
| -25% | -$21.7K | ﹤0.01% | 3112 |
|
|
2015
Q2 | $95K | Sell |
4
-1
| -20% | -$23.8K | ﹤0.01% | 2966 |
|
|
2015
Q1 | $94K | Buy |
+5
| New | +$94K | ﹤0.01% | 2929 |
|